Benjamin K Tomlinson (Benjamin Tomlinson)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Leland L Metheny, Ronald Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius, Jiasheng Wang, Lisa Ciarrone, Shelby Kopp, Robin D Convents, Navneet S Majhail, Paolo F Caimi, Folashade Otegbeye, Brenda W Cooper, Molly Gallogly, Ehsan Malek, Benjamin K Tomlinson, Aaron T Gerds, Betty Hamilton, Sergio A Giralt, Miguel-Ángel Perales, Marcos J deLima
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia. Blood advances 8 (6) (2024)
Leland Metheny, Ronald M Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius, Jiasheng Wang, Lisa Ciarrone, Shelby Kopp, Robin Convents, Navneet S Majhail, Paolo F Caimi, Folashade Otegbeye, Brenda W Cooper, Molly M Gallogly, Ehsan Malek, Benjamin K Tomlinson, Aaron T Gerds, Betty K Hamilton, Sergio A Giralt, Miguel-Ángel Perales, Marcos J deLima
A multicenter study of posttransplant low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia. Blood advances (2024)
Leland L Metheny, Ronald Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius, Jiasheng Wang, Lisa Ciarrone, Shelby Kopp, Robin D Convents, Navneet S Majhail, Paolo F Caimi, Folashade Otegbeye, Brenda W Cooper, Molly Gallogly, Ehsan Malek, Benjamin K Tomlinson, Aaron T Gerds, Betty Hamilton, Sergio A Giralt, Miguel-Ángel Perales, Marcos J deLima
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia. Blood advances 8 (6) (2024)
Leland L Metheny, Ronald Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius, Jiasheng Wang, Lisa Ciarrone, Shelby Kopp, Robin D Convents, Navneet S Majhail, Paolo F Caimi, Folashade Otegbeye, Brenda W Cooper, Molly Gallogly, Ehsan Malek, Benjamin K Tomlinson, Aaron T Gerds, Betty Hamilton, Sergio A Giralt, Miguel-Ángel Perales, Marcos J deLima
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia. Blood advances 8 (6) (2024)
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah K Choe, Mark R Litzow, Camille N Abboud, Nebu Koshy, Patrick Joseph Stiff, Benjamin K Tomlinson, Sunil Abhyankar, James M Foran, Parameswaran N Hari, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie J Orozco, Katarzyna Jamieson, Margarida Silverman, Koen van Besien, Michael Schuster, Arjun Datt Law, Karilyn T M Larkin, Neeta Pandit-Taskar, Scott Douglas Rowley, Pashna Munshi, Rachel Cook, Moshe Y Levy, Hillard M Lazarus, Brenda M Sandmaier, John M Pagel, Vijay Reddy, James MacDougall, Kathleen McNamara, Jennifer Spross, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, Avinash Desai, Sergio A Giralt
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mikkael A Sekeres, Pau Montesinos, Jan Novak, Jian-Xiang Wang, Deepa Jeyakumar, Benjamin K Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C Taussig, Hervé Dombret, Akil A Merchant, Naveed Shaik, Thomas O'Brien, Whijae Roh, Xueli Liu, Wendy Ma, Christine G DiRienzo, Geoffrey Chan, Jorge E Cortes
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia (2023)
Alaa M Kassem, Melissa C Keinath, Jason A Adler, Ramya Gadde, Benjamin K Tomlinson, Shashirekha Shetty
ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings. British journal of haematology (2023)
Audrey N Jajosky, Navid Sadri, Howard J Meyerson, Kwadwo A Oduro, Ashwin Kelkar, Brynn Fitzgerald, Benjamin K Tomlinson, Erika M Moore, Rose C Beck
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia. European journal of haematology 106 (4) (2021)
Jiasheng Wang, Marcos de Lima, Brenda W Cooper, Kirsten Boughan, Leland Metheny, Folashade Otegbeye, Paolo F Caimi, Molly Gallogly, Ehsan Malek, Shufen Cao, Pingfu Fu, Brett Glotzbecker, Nicholas K Schiltz, Benjamin K Tomlinson
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia. Leukemia & lymphoma 62 (6) (2021)
Gouri Dharmavaram, Shufen Cao, Suchitra Sundaram, Sabarish Ayyappan, Kirsten Boughan, Molly Gallogly, Ehsan Malek, Leland Metheny, Benjamin K Tomlinson, Folashade Otegbeye, Hillard M Lazarus, Brenda Cooper, Pingfu Fu, Marcos de Lima, Paolo F Caimi
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models. American journal of hematology 95 (8) (2020)
Benjamin K Tomlinson, Philipp W Raess, Rose C Beck, Erika M Moore
Erythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapy. British journal of haematology 188 (6) (2020)
Benjamin K Tomlinson, Joseph M Tuscano, Mehrdad Abedi, Jeanna Welborn, Mili Arora, Robert T O'Donnell, Ted Wun, Brian A Jonas
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia. American journal of hematology 94 (11) (2019)